|
Volumn 18, Issue 2, 2011, Pages 80-84
|
Preoperative therapy: Recent findings
|
Author keywords
Breast cancer; Preoperative chemotherapy; Preoperative therapy; Regimen
|
Indexed keywords
ANASTROZOLE;
ANTHRACYCLINE;
CAPECITABINE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
EPIRUBICIN;
FLUOROURACIL;
NAVELBINE;
PACLITAXEL;
PREDNISONE;
TAMOXIFEN;
TAXANE DERIVATIVE;
TRASTUZUMAB;
VINCRISTINE;
ARTICLE;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CANCER HORMONE THERAPY;
CANCER RESISTANCE;
CANCER SURVIVAL;
DISEASE FREE SURVIVAL;
GENE OVEREXPRESSION;
HUMAN;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
OVERALL SURVIVAL;
PARTIAL MASTECTOMY;
PREDICTION;
PREOPERATIVE CARE;
PRIORITY JOURNAL;
SYSTEMIC THERAPY;
TREATMENT PLANNING;
AGED;
AGED, 80 AND OVER;
BREAST NEOPLASMS;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
MIDDLE AGED;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
|
EID: 79956364214
PISSN: 13406868
EISSN: 18804233
Source Type: Journal
DOI: 10.1007/s12282-010-0227-4 Document Type: Article |
Times cited : (7)
|
References (6)
|